Editor's note: In an effort to keep you informed of products that can help dental practices during the COVID-19 pandemic, Dental Economics columnist Howard Glazer, DDS, FAGD, has authored a special multipart series. In each installment, he reviews a product that can assist you during this challenging time.
LuxaCrown from DMG America
In this new era of “emergencies only” we may not be able to prepare and make a crown for a patient. Or maybe we want to wait a bit of time to ensure the tooth is salvageable in the long term. LuxaCrown from DMG America allows us to provide patients with a chairside option for longer-lasting temporization that is semipermanent.
LuxaCrown provides long-term protection while restoring the form and function to the tooth. This provisional crown material can last up to five years. Whether it is for long-term healing, correcting vertical dimension, or esthetic corrections, LuxaCrown is an incredibly durable material. It is available in an automix cartridge that can easily provide about 36 single units and 24 three-unit bridges. It is also a great solution for indications such as crowns for primary teeth, postendodontic therapy, a temporary for an implant crown, or even in treating patients who suffer from bulimia and chronic bruxism.
LuxaCrown is fabricated in the same simple manner as when using LuxaTemp Ultra. The distinct advantage here is that in one visit you can provide the patient with a strong, aesthetic, quasi-long-term provisional that, according to manufacturer’s in vitro testing, can be worn up to five years. LuxaCrown uses the same 10:1 dispensing unit as LuxaTemp. There are 8 shades: A1, A2, A3, A3.5, B1, B3, C2, and D2.
If the occasion arises where either a long-term, strong, and aesthetic provisional is needed or an alternative to a “permanent” crown made chairside is indicated, look no further than LuxaCrown. This unique material is made by the same manufacturer, DMG, that is known worldwide for providing excellence in provisional restorations.
Additional articles in this series
Editor's note: This article first appeared in the Morning Briefing, a daily newsletter published by Dental Economics, DentistryIQ, Perio-Implant Advisory, and RDH. Learn more and subscribe here. For full coverage of the coronavirus pandemic, visit the DentistryIQ COVID-19 Resource Center.
